Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie S Y Chew

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell|December 1, 2021
Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamicsXin-Xiang Lim, Bo Shu, Shuijun Zhang, et al.
Vaccine|March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humansJustin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Vaccine|July 1, 2025
AS01-adjuvanted vaccine alters baseline correlates of T cell response to varicella zoster virus in older adultsCandice C Y Chan, Justin S G Ooi, Clara W T Koh, et al.
Nature Communications|June 21, 2020
High flavivirus structural plasticity demonstrated by a non-spherical morphological variantSeamus R Morrone, Valerie S Y Chew, Xin-Ni Lim, et al.
Plos Pathogens|February 23, 2021
Antibody affinity versus dengue morphology influences neutralizationGuntur Fibriansah, Elisa X Y Lim, Jan K Marzinek, et al.
Ebiomedicine|May 10, 2026
Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infectionAyesa Syenina, Christine Y L Tham, Danny J H Tng, et al.
Med (New York, N.Y.)|April 27, 2023
RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complicationEugenia Z Ong, Clara W T Koh, Danny J H Tng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell|December 1, 2021
Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamicsXin-Xiang Lim, Bo Shu, Shuijun Zhang, et al.
Vaccine|March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humansJustin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Vaccine|July 1, 2025
AS01-adjuvanted vaccine alters baseline correlates of T cell response to varicella zoster virus in older adultsCandice C Y Chan, Justin S G Ooi, Clara W T Koh, et al.
Nature Communications|June 21, 2020
High flavivirus structural plasticity demonstrated by a non-spherical morphological variantSeamus R Morrone, Valerie S Y Chew, Xin-Ni Lim, et al.
Plos Pathogens|February 23, 2021
Antibody affinity versus dengue morphology influences neutralizationGuntur Fibriansah, Elisa X Y Lim, Jan K Marzinek, et al.
Ebiomedicine|May 10, 2026
Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infectionAyesa Syenina, Christine Y L Tham, Danny J H Tng, et al.
Med (New York, N.Y.)|April 27, 2023
RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complicationEugenia Z Ong, Clara W T Koh, Danny J H Tng, et al.
Pageof 1